ストックスクリーナーアプリを入手
287.97
0.56%
-1.61
アフターアワーズ：
288.60
0.63
+0.22%
前日終値:
$289.58
開ける：
$288.84
24時間の取引高:
1.40M
Relative Volume:
0.60
時価総額：
$155.03B
収益：
$34.76B
当期純損益:
$6.62B
株価収益率:
23.55
EPS:
12.23
ネットキャッシュフロー:
$10.61B
1週間 パフォーマンス:
-2.86%
1か月 パフォーマンス:
-6.07%
6か月 パフォーマンス:
-5.84%
1年 パフォーマンス:
-11.92%
1日の値動き範囲:
$286.65
$290.25
1週間の範囲:
$286.53
$299.90
52週間の値動き範囲:
$253.30
$339.17
Amgen Inc Stock (AMGN) Company Profile
AMGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
287.97 | 155.90B | 34.76B | 6.62B | 10.61B | 12.23 |
|
LLY
Lilly Eli Co
|
734.17 | 659.82B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
176.79 | 425.05B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
208.06 | 368.08B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
126.89 | 245.16B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
84.07 | 212.29B | 63.43B | 16.42B | 14.72B | 6.49 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-20 | 再開されました | Guggenheim | Neutral |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-14 | ダウングレード | Truist | Buy → Hold |
| 2024-09-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-05-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-02 | アップグレード | Truist | Hold → Buy |
| 2023-10-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-17 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 再開されました | BofA Securities | Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-04-24 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 繰り返されました | Truist | Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Underperform |
| 2022-10-31 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-09 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-09 | 繰り返されました | Jefferies | Buy |
| 2022-02-09 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-09 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-09-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 開始されました | Daiwa Securities | Buy |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | アップグレード | Truist | Hold → Buy |
| 2020-10-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | ダウングレード | Truist | Buy → Hold |
| 2020-10-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 再開されました | Guggenheim | Neutral |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-03-30 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-17 | 再開されました | Morgan Stanley | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-11-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-05-23 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Amgen Inc (AMGN) 最新ニュース
Colorado Board Adopts Medicare Maximum Fair Price For Enbrel, Assumes Amgen ‘Amenable’ - insights.citeline.com
Should you hold or exit Amgen Inc. now2025 Breakouts & Breakdowns & Real-Time Volume Triggers - Newser
Piper Sandler Boosts Amgen (NASDAQ:AMGN) Price Target to $342.00 - MarketBeat
Amgen Inc. $AMGN Shares Sold by Corebridge Financial Inc. - MarketBeat
Amgen Inc. $AMGN Holdings Cut by Fuller & Thaler Asset Management Inc. - MarketBeat
American Century Companies Inc. Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Lowered by Wellington Management Group LLP - MarketBeat
Ameriprise Financial Inc. Grows Position in Amgen Inc. $AMGN - MarketBeat
Allstate Corp Has $5.73 Million Stake in Amgen Inc. $AMGN - MarketBeat
Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic - GlobeNewswire Inc.
Amgen Inc. $AMGN Shares Sold by Price T Rowe Associates Inc. MD - MarketBeat
Martingale Asset Management L P Cuts Position in Amgen Inc. $AMGN - MarketBeat
Stock Analysis | Amgen OutlookMixed Signals Amid Strong Fundamentals - AInvest
United Asset Strategies Inc. Has $9.45 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Position Lifted by CW Advisors LLC - MarketBeat
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Comparing Amgen Inc. in custom built stock radarsExit Point & Entry Point Confirmation Signals - Newser
Amgen (AMGN) Gains FDA Approval For Broadened Repatha® Use In Cardiovascular Risk Management - simplywall.st
Beone sells off Amgen Imdelltra royalties for $950M - BioWorld MedTech
Comerica Bank Has $54.37 Million Holdings in Amgen Inc. $AMGN - MarketBeat
AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock? - TradingView
Amgen Inc. $AMGN Stock Position Reduced by MetLife Investment Management LLC - MarketBeat
Campbell & CO Investment Adviser LLC Has $4.32 Million Stake in Amgen Inc. $AMGN - MarketBeat
Quantitative Investment Management LLC Has $2.91 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Custom strategy builders for tracking Amgen Inc.Trade Volume Summary & Free Technical Pattern Based Buy Signals - Newser
How Does Amgen Stack Up After Humira Biosimilar Launch and Recent Price Swings? - simplywall.st
Cracking KRAS - Amgen
Amgen Inc. $AMGN Stock Position Cut by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Royalty Pharma (RPRX) Acquires US$885 Million Royalty Interest In Amgen's Imdelltra - Yahoo Finance
BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up - Yahoo Finance
Amgen Inc. $AMGN Position Decreased by Candriam S.C.A. - MarketBeat
Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales - BioPharma Dive
Royalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drug - Reuters
Amgen Inc. $AMGN Shares Bought by Erste Asset Management GmbH - MarketBeat
Major FDA Win: Amgen's Repatha Now Available to Millions More At-Risk Heart Patients Without CV Disease - Stock Titan
APG Asset Management N.V. Cuts Position in Amgen Inc. $AMGN - MarketBeat
SVB Wealth LLC Trims Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Bahl & Gaynor Inc. - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Biondo Investment Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Kestra Advisory Services LLC - MarketBeat
Compound Planning Inc. Has $2.09 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Dorsey & Whitney Trust CO LLC Has $6.24 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Reversal indicators forming on Amgen Inc. stockDollar Strength & Safe Capital Growth Trade Ideas - Newser
Visual analytics tools that track Amgen Inc. performanceTrade Entry Report & Reliable Price Breakout Signals - Newser
Amgen Inc. $AMGN Shares Acquired by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat
Amgen Stock (AMGN) Opinions on Dividend Announcement and Clinical Trial Success - Quiver Quantitative
Edgar Lomax Co. VA Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Northern Trust Corp - MarketBeat
Amgen Inc. $AMGN Stock Holdings Cut by Round Hill Asset Management - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Acquires 176,947 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen’s Promising Phase 3 Study on Dazodalibep for Sjögren’s Syndrome - TipRanks
Amgen Inc (AMGN) 財務データ
収益
当期純利益
現金流量
EPS
0.60%
0.72%
大文字化:
|
ボリューム (24 時間):